Drawing for OMEROS

USPTO serial 97672493

OMEROS

Reviewed by CopyMark Law Group

Status 819
Filing date
Status date
Registration date
—
Examiner
KNIGHT, TROY FRANK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OMEROS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kelley B. Harrington

Kelley B. Harrington Cooley LLP1299 Pennsylvania Avenue NW, Suite 700ATTN: IP Docketing DepartmentWashington, DC 20004

Goods and services

ClassDescriptionStatusFirst use
005Biological and pharmaceutical preparations for the treatment of transplant complications, and endothelial, renal, hematological, autoimmune, neurological, inflammatory, and immunological diseases and disordersACTIVEFeb 16, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 27, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 26, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 25, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 25, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 4, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 5, 2026IUAFUSE AMENDMENT FILED—
Jun 5, 2026EXT5SOU EXTENSION 5 FILED—
Jun 5, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 5, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2025EX4GSOU EXTENSION 4 GRANTED—
Nov 17, 2025EXT4SOU EXTENSION 4 FILED—
Nov 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 8, 2025EX3GSOU EXTENSION 3 GRANTED—
Apr 7, 2025EXT3SOU EXTENSION 3 FILED—
Apr 7, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 14, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 14, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 14, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 14, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 14, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 4, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2024EX2GSOU EXTENSION 2 GRANTED—
Oct 4, 2024EXT2SOU EXTENSION 2 FILED—
Oct 4, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2024EX1GSOU EXTENSION 1 GRANTED—
May 15, 2024EXT1SOU EXTENSION 1 FILED—
May 15, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 12, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 23, 2023DOCKASSIGNED TO EXAMINER—
Dec 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance